(Q41177254)

27 September 2017

title

Pharmacological characterization of a Chinese hamster ovary cell line transfected with the human CCK-B receptor gene (English)

1 reference

27 September 2017

Dunlop J

1

1 reference

27 September 2017

Brammer N

series ordinal

2

1 reference

27 September 2017

Ennis C

series ordinal

3

1 reference

27 September 2017

publication date

1 August 1996

1 reference

27 September 2017

1 reference

27 September 2017

volume

30

1 reference

27 September 2017

issue

4

1 reference

27 September 2017

page(s)

359-363

1 reference

Two brain cholecystokinin receptors: implications for behavioral actions.

27 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0143-4179%2896%2990025-6

7 January 2021

Cholecystokinin-tetrapeptide induces panic attacks in patients with panic disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0143-4179%2896%2990025-6

7 January 2021

The panicogenic effects of cholecystokinin-tetrapeptide are antagonized by L-365,260, a central cholecystokinin receptor antagonist, in patients with panic disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0143-4179%2896%2990025-6

7 January 2021

Cholecystokinin and anxiety

1 reference

https://api.crossref.org/works/10.1016%2FS0143-4179%2896%2990025-6

7 January 2021

The selective CCK-B receptor antagonist L-365,260 enhances morphine analgesia and prevents morphine tolerance in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0143-4179%2896%2990025-6

7 January 2021

Molecular and pharmacological characterization of the human CCKB receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0143-4179%2896%2990025-6

7 January 2021

Species specificity of pharmacological characteristics of CCK-B receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0143-4179%2896%2990025-6

7 January 2021

A new potent and selective non-peptide gastrin antagonist and brain cholecystokinin receptor (CCK-B) ligand: L-365,260

1 reference

https://api.crossref.org/works/10.1016%2FS0143-4179%2896%2990025-6

7 January 2021

Differentiation of central cholecystokinin receptor binding sites using the non-peptide antagonists MK-329 and L-365,260.

1 reference

https://api.crossref.org/works/10.1016%2FS0143-4179%2896%2990025-6

7 January 2021

Novel and potent gastrin and brain cholecystokinin antagonists from Streptomyces olivaceus. Taxonomy, fermentation, isolation, chemical conversions, and physico-chemical and biochemical properties.

1 reference

https://api.crossref.org/works/10.1016%2FS0143-4179%2896%2990025-6

7 January 2021

Tetronothiodin, a novel cholecystokinin type-B receptor antagonist produced by Streptomyces sp

1 reference

https://api.crossref.org/works/10.1016%2FS0143-4179%2896%2990025-6

7 January 2021

Tetronothiodin, a novel CCKB receptor ligand, antagonizes cholecystokinin-induced Ca2+ mobilization in a pituitary cell line

1 reference

https://api.crossref.org/works/10.1016%2FS0143-4179%2896%2990025-6

7 January 2021

Characterization of the novel CCK analogs JMV-180, JMV-320, and JMV-332 in H345 cells

1 reference

https://api.crossref.org/works/10.1016%2FS0143-4179%2896%2990025-6

7 January 2021

Cholecystokinin increases intracellular Ca2+ concentration in the Human JURKAT T Lymphocyte cell line

1 reference

https://api.crossref.org/works/10.1016%2FS0143-4179%2896%2990025-6

7 January 2021

10.1016/S0143-4179(96)90025-6

Identifiers

DOI

1 reference

27 September 2017

1 reference